Tilray CEO: Opportunities in clinical cannabis are substantial

Tilray CEO: Opportunities in clinical cannabis are substantial

Tilray’s stock is up as of late, nonetheless level-headed down 80 percent from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon about the firm’s quarterly earnings and what’s subsequent for the business.For safe entry to to live and distinctive video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV: n
» Subscribe to CNBC: C
» Subscribe to CNBC Basic:

Turn to CNBC TV for basically the most up-to-date stock market news and diagnosis. From market futures to live impress updates CNBC is the leader in business news worldwide.

The Recordsdata with Shepard Smith is CNBC’s day-to-day news podcast offering deep, non-partisan coverage and perspective on the day’s most necessary reports. On hand to listen by 8: 30pm ET / 5: 30pm PT day-to-day starting up September 30:

Connect with CNBC Recordsdata On-line
Earn basically the most up-to-date news: /
Apply CNBC on LinkedIn: C
Apply CNBC Recordsdata on Fb: C
Apply CNBC Recordsdata on Twitter: C
Apply CNBC Recordsdata on Instagram: C

for/simplest-credit-playing cards/

#CNBC
#CNBCTV

You May Also Like

About the Author: AR Legal Cannabis News

Leave a Reply